Index Entries

2087 Results
TitleIS Publication Date
Amid Growing Evidence of Conflicts of Interest and Obdurate Groupthink in Medical Journals, Researchers Must Entertain Contrarian IdeasJanuary 23, 2025
Amyloidogenesis of SARS-CoV-2 Spike ProteinMay 17, 2022
An autopsy case report of fulminant myocarditis: Following mRNA COVID-19 vaccinationDecember 2022
An Evidence Based Scientific Analysis of Why Masks are Ineffective, Unnecessary, and HarmfulOctober 12, 2020
An Independent Analysis of the Manufacturing and Quality Issues of the BNT162b BioNTech/Pfizer Quasi-vaccine based on the European Medicines Agency’s Public Assessment Report (EPAR)October 29, 2022
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodiesMay 24, 2021
An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 VaccineMarch 17, 2022
An observational and Mendelian randomisation study on vitamin D and COVID-19 risk in UK BiobankSeptember 14, 2021
An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in VietnamSeptember 29, 2021
An open debate on SARS-CoV-2’s proximal origin is long overdueFebruary 7, 2021
An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021July 1, 2021
An overview and single-arm meta-analysis of immune-mediated adverse events following COVID-19 vaccinationJune 11, 2024
An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine AdjuvantsNovember 18, 2021
An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatmentJuly 22, 2021
An overview of the MATH+, I-MASK+ and I-RECOVER Protocols — A Guide to the Management of COVID-19
An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management RecommendationsAugust 18, 2021
Anakinra for severe forms of COVID-19: a cohort studyMay 29, 2020
Analysis of COVID-19 vaccine death reports from the Vaccine Adverse Events Reporting System (VAERS) Database Interim: Results and AnalysisJune 2021
Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 VaccinesJanuary 18, 2022
Analysis of the adverse events following the mRNA-1273 COVID-19 vaccineSeptember 25, 2023
Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panelDecember 15, 2021
Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic CountriesJune 14, 2022
Analysis of vitamin D level among asymptomatic and critically ill COVID?19 patients and its correlation with infammatory markers
Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG AllergySeptember 28, 2021
Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic ApproachesOctober 1, 2024
Anecdotals (documentary)December 2022
Anthem BCBS Medicaid - COVID-19 Vaccine Provider Incentive programOctober 21, 2021
Anthony Fauci emails acquired by FOIA request
Anthony Fauci on C-SPAN’s Washington JournalOctober 11, 2004
Anti-recoverin Antibody-Associated Post-acute COVID Vaccination Syndrome After BNT162b2 in HLA-B27-Positive Spondylarthritis: A Case ReportAugust 14, 2024
Anti-SARS-CoV-2 Receptor-Binding Domain Antibody Evolution after mRNA VaccinationOctober 7, 2021
Anti-science case study: COVID-19 vaccines’ effectiveness and safety exaggeratedMay 23, 2024
Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR PathwayOctober 15, 2011
Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaeniaJuly 7, 2021
Antibody levels decrease after two doses of Pfizer vaccine – studyOctober 7, 2021
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersFebruary 11, 2021
Antibody-dependent enhancement
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapiesSeptember 9, 2020
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infectionsMay 31, 2021
Antiviral Effect of Budesonide against SARS-CoV-2July 20, 2021
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trialJune 18, 2021
Antiviral treatments [Molnupiravir] lead to the rapid accrual of hundreds of SARS-CoV-2 mutations in immunocompromised patients
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2October 11, 2023
Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccineJune 24, 2021
Apparent Cytotoxicity and Intrinsic Cytotoxicity of Lipid Nanomaterials Contained in a COVID-19 mRNA VaccineOctober 16, 2023
Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 InfectionDecember 12, 2022
Appendix 1: estimation of number needed to vaccinate to prevent a COVID-19 hospitalisation for primary vaccination, booster vaccination (3rd dose), autumn 2022 and spring 2023 booster for those newly in a risk groupJanuary 25, 2023
APPENDIX 2.2: Cumulative and Interval Summary Tabulation of Serious and Non-Serious Adverse Reactions from Post-Marketing Data SourcesJune 21, 2022
Approval letter: Biologics License Application (BLA) Approval for BioNTech (Pfizer) Manufacturing GmbHAugust 23, 2021
Are COVID-19 Vaccines in Pregnancy as Safe and Effective as the Medical Industrial Complex Claim? Part IFebruary 8, 2025